Geneva Advisors’s NuVasive, Inc. NUVA Stock Holding History

Geneva Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1.34M	Buy	17,369 +555	+3%	+$41.5K	0.02%	307
2017 Q1	$1.26M	Buy	16,814 +860	+5%	+$62.4K	0.02%	306
2016 Q4	$1.07M	Sell	15,954 -4,326	-21%	-$279K	0.02%	319
2016 Q3	$1.35M	Buy	20,280 +740	+4%	+$47.1K	0.03%	259
2016 Q2	$1.17M	Buy	19,540 +653	+3%	+$35.3K	0.02%	280
2016 Q1	$919K	Sell	18,887 -965	-5%	-$43.8K	0.02%	314
2015 Q4	$1.07M	Buy	19,852 +7,861	+66%	+$401K	0.02%	291
2015 Q3	$578K	Buy	+11,991	New	+$620K	0.01%	367

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Geneva Advisors's NUVA Position: Q2 2017 in Review

Geneva Advisors increased its NuVasive, Inc. (NUVA) stake by 3.3% in Q2 2017, buying an estimated $41.5K and bringing the position to 17,369 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #307.

Geneva Advisors first reported a position in NUVA in Q3 2015 and has held it in 8 quarters since. The position peaked at $1.35M in Q3 2016. 298 funds tracked by Wall St. Rank hold NUVA as of Q2 2017.

Geneva Advisors held 17,369 shares of NuVasive, Inc. worth $1.34M as of Q2 2017.
Geneva Advisors bought 555 NuVasive, Inc. shares in Q2 2017, an estimated $41.5K.
NuVasive, Inc. made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #307 holding.
Geneva Advisors first reported a position in NuVasive, Inc. in Q3 2015 and has held it in 8 quarters since.
Geneva Advisors's NuVasive, Inc. position peaked at $1.35M in Q3 2016.
298 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.